LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Diagnostic Accuracy Demonstrated in Oral Glucose Tolerance Test

By LabMedica International staff writers
Posted on 02 Jan 2019
Image: During the oral glucose tolerance test (OGTT) blood glucose is tested two hours after drinking 75 grams of glucose, but a test one hour afterwards may be sufficient to diagnose diabetes (Photo courtesy of the US National Institutes of Health).
Image: During the oral glucose tolerance test (OGTT) blood glucose is tested two hours after drinking 75 grams of glucose, but a test one hour afterwards may be sufficient to diagnose diabetes (Photo courtesy of the US National Institutes of Health).
The incidence of overweight and obesity among children has increased dramatically in recent decades, with about one-third of children in the USA currently being either overweight or obese. Being overweight in early childhood increases risk for later obesity.

During an oral glucose tolerance test (OGTT), morphological features of the glucose curve, monophasic curve, glucose peak more than 30 minutes and 1‐hr glucose of equal to or greater than 155mg/dL, maybe associated with higher prediabetes risk, but their reproducibility and predictive ability in adolescents with obesity are unknown.

Scientists working with the Essentia Health-Duluth Clinic (Duluth, MN, USA) analyzed data from adolescent girls with obesity but without diabetes who underwent a multiple-sample OGTT at baseline (n = 93), six weeks (n = 83) and one year (n = 72) as part of a randomized controlled trial. They obtained plasma samples to measure glucose and insulin concentrations at 0, 30, 60, 90 and 120 minutes. Prediabetes was defined as a fasting glucose level between 100mg/dL and 126 mg/dL and/or a 2-hour glucose level between 140 mg/dL and 200 mg/dL. They compared short-term reproducibility (baseline to six weeks) and predictive ability for prediabetes (baseline to one year) for each feature using standard fasting and 2-hour OGTT criteria.

The percentage of youths with prediabetes (12%) was the same at baseline and at six weeks. Six girls diagnosed with prediabetes at baseline were reclassified as having normal glucose tolerance at six weeks, whereas eight girls with normal glucose tolerance at baseline were reclassified as having prediabetes at six weeks. Among 72 girls examined at 1-year follow-up, 11 had prediabetes at baseline and seven had prediabetes at one year. Compared with OGTT criteria, ROC-AUC was lower for monophasic curve variable (0.42), but not different for 1-hour glucose (0.67), glucose peak at 30 minutes (0.68) or a combination of 1-hour glucose and glucose peak variables (0.77).

Kannan Kasturi, MD, a pediatric endocrinologist and lead author of the study, said, “In up to 25% of youth who develop type 2 diabetes, the fasting, two-hour glucose concentration of HbA1c may be below the prediabetes diagnostic thresholds two years prior to diabetes diagnosis. The need to improve risk stratification is further amplified in adolescent girls who have high rates of developing type 2 diabetes and may benefit from targeted, intensive intervention programs.” The study was published on December 6, 2018, in the journal Pediatric Diabetes.

Related Links:
Essentia Health-Duluth Clinic

Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Capillary Blood Collection Tube
IMPROMINI M3

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more